Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Asian Pac J Cancer Prev ; 21(6): 1637-1644, 2020 Jun 01.
Article in English | MEDLINE | ID: mdl-32592358

ABSTRACT

BACKGROUND/AIM: The Glutathione S-transferases (GSTs) are important carcinogen-metabolizing enzymes. Polymorphisms involved in these enzymes can modulate the development and treatment of head and neck cancer. To investigate the association of GSTs polymorphisms with head and neck cancer and risk factors, clinical-pathological features, and survival time of the patients treated with chemotherapy and/or radiotherapy. METHODS: The GST gene polymorphisms were evaluated in 197 cases and 514 controls by PCR-RFLP-Polymerase Chain Reaction Restriction Fragment Length Polymorphism. RESULTS: The GSTP-313 was associated with a decreased risk for HNSCC (p=0.050). The GSTP1 haplotype analysis revealed a higher frequency of the AC and AT haplotypes in the case group than in the control group (p=0.013 and p=0.019, respectively), and the opposite for G-C haplotype (p = 0.015). Yet, the different combinations between the genotypes were associated with an increased risk of cancer. The study showed no association between the polymorphisms and primary tumor site, clinical-pathological characteristics, treatment (chemotherapy and/or radiotherapy) and survival time of the patients. CONCLUSION: The GST polymorphisms combination showed an increased risk for carcinogenesis, and studies with larger casuistry can contribute to the clarification of the role in individual patient differences for the response to chemotherapy and/or radiotherapy and identify biomarkers of susceptibility.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Biomarkers, Tumor/genetics , Chemoradiotherapy/methods , Glutathione S-Transferase pi/genetics , Head and Neck Neoplasms/pathology , Polymorphism, Genetic , Squamous Cell Carcinoma of Head and Neck/pathology , Adult , Aged , Aged, 80 and over , Cisplatin/administration & dosage , Female , Fluorouracil/administration & dosage , Follow-Up Studies , Genetic Predisposition to Disease , Haplotypes , Head and Neck Neoplasms/genetics , Head and Neck Neoplasms/therapy , Humans , Male , Methotrexate/administration & dosage , Middle Aged , Prognosis , Retrospective Studies , Risk Factors , Squamous Cell Carcinoma of Head and Neck/genetics , Squamous Cell Carcinoma of Head and Neck/therapy
2.
Pediatr Hematol Oncol ; 30(7): 616-22, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23802802

ABSTRACT

Juvenile nasopharyngeal angiofibroma (JNA) is a vascular tumor of the nasopharynx that accounts for 0.5% of all cancers of the head and neck. It primarily affects males aged 14-25 years. Of the many genes that mediate the development of JNA, GSTM1 has been most frequently associated with this vascular tumor. The loss of expression of GSTM1 (null genotype) is linked to the development of these tumors. The aim of this cross-sectional case study was to examine the prevalence of the GSTM1-null genotype in Brazilian patients with JNA. DNA was extracted from the leukocytes of blood samples from 10 patients. GSTM1 genotypes were analyzed using a PCR-based assay that was designed to identify the wild-type allele of GSTM1. All 10 patients (100%) were males, with a mean age of 17.8 years. The null genotype for GSTM1 was noted in 4 patients (40%)-1 (10%) at Fisch stage I, 1 (10%) at stage III, and 2 (20%) at stage II. No patient with this genotype had stage IV disease. There was no correlation between Fisch classification and GSTM1 genotype (P = .5695). The correlation between age at diagnosis and GSTM1 genotype was not significant (P = .728). The present findings indicate that there is evidence of an association between the GSTM1-null genotype and JNA in this studied Brazilian population.


Subject(s)
Alleles , Angiofibroma/genetics , Genotype , Glutathione Transferase/genetics , Nasopharyngeal Neoplasms/genetics , Adolescent , Adult , Angiofibroma/epidemiology , Angiofibroma/pathology , Brazil/epidemiology , Child , Cross-Sectional Studies , Female , Humans , Male , Nasopharyngeal Neoplasms/epidemiology , Nasopharyngeal Neoplasms/pathology , Neoplasm Staging
3.
Arq. int. otorrinolaringol. (Impr.) ; 12(4): 596-599, out.-dez. 2008. ilus
Article in English, Portuguese | LILACS | ID: lil-525766

ABSTRACT

Introdução: A Fasceíte Necrotizante é uma infecção bacteriana caracterizada por extensa necrose dos tecidos, que pode envolver desde a pele até a musculatura. É mais prevalente na população adulta do que pediátrica e os principais locais de acometimento são o tronco e extremidades, sendo a região da cabeça e pescoço menos comumente atingida. Os patógenos mais freqüentemente isolados são Streptococcus pyogenes (grupo A) e Staphilococcus aureus. O exame anatomopatológico é o melhor método diagnóstico identificando precocemente a doença. O suporte clínico, o debridamento cirúrgico, além de antibioticoterapia endovenosa são fundamentais para o tratamento. Objetivo: Relatar o caso de um lactente que apresentou Fasceíte Necrotizante na região cervical. Relato do caso: Lactente, sexo masculino, branco, 2 meses de idade, previamente hígido, com quadro de Fasceíte Necrotizante em região cervical anterior e lateral direita. Com tratamento adequado o paciente obteve excelente recuperação sem apresentar importantes alterações estéticas ou funcionais. Conclusão: A Fasceíte Necrotizante cervicofacial é rara em crianças. O debridamento cirúrgico precoce é necessário para controlar a infecção mesmo que possa resultar em ferimentos grandes e profundos. A antibioticoterapia de amplo espectro e o suporte hemodinâmico também são fundamentais para o sucesso terapêutico.


Introduction: Necrotizing fasciitis is a bacterial infection characterized by extensive necrosis of tissues, and may include skin and muscles. It's more frequent in adults than in children and generally involves the trunk and extremities. Head and neck area is less commonly affected. The most frequently isolated pathogens are the Streptococcus pyogenes (group A) and Staphylococcus aureus. The anatomopathological exam is the best diagnostic method, which early identifies the disease. The clinical support, surgical debridement, and the intravenous antibiotic therapy, are fundamental for the treatment. Objective: To report a case of an infant who suffered from Cervical Necrotizing Fasciitis. Case Report: Infant, male sex, white, 2 months old, previously healthy, with Necrotizing Fasciitis involving the frontal and right lateral cervical regions. After adequate treatment the patient obtained excellent recovery without presenting important aesthetic or functional alterations. Conclusion: The Cervical Necrotizing Fasciitis is uncommon in children. The early surgical debridement is necessary to control the infection, even if it may result in great and deep injuries. The wide spectrum antibiotic therapy and hemodynamic support are also basic for the therapeutic success.


Subject(s)
Humans , Male , Infant , Bacterial Infections , Drainage , Fasciitis, Necrotizing , Neck/microbiology
SELECTION OF CITATIONS
SEARCH DETAIL
...